Stem Cell Therapy for Jaw Bone Disease in Mice
Author Information
Author(s): Kikuiri Takashi, Kim Insoo, Yamaza Takyoshi, Akiyama Kentaro, Zhang Qunzhou, Li Yunsheng, Chen Chider, Chen WanJun, Wang Songlin, Le Anh D, Shi Songtao
Primary Institution: University of Southern California School of Dentistry
Hypothesis
Can mesenchymal stem cells (MSCs) cure bisphosphonate-related osteonecrosis of the jaw (BRONJ) in a mouse model?
Conclusion
The study found that MSC infusion can prevent and cure BRONJ-like disease in mice by restoring immune balance.
Supporting Evidence
- MSCs restored the balance of immune cells in treated mice.
- BRONJ-like lesions were induced by high doses of zoledronate and dexamethasone.
- Control mice without treatment showed normal healing.
- Infusion of Tregs also prevented BRONJ-like lesions.
Takeaway
Scientists used mice to test if special cells called stem cells can help heal a serious jaw bone disease caused by certain medications.
Methodology
Mice were treated with zoledronate and dexamethasone to induce BRONJ-like disease, followed by MSC infusion to assess healing.
Potential Biases
Potential bias in the selection of treatment groups and the interpretation of results.
Limitations
The study was conducted in mice, which may not fully replicate human responses.
Participant Demographics
C57BL/6J and beige nude/nude Xid (III) female mice, aged 8 to 10 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website